Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$8.83 - $17.61 $38,322 - $76,427
4,340 New
4,340 $39,000
Q3 2022

Nov 09, 2022

BUY
$16.06 - $26.39 $9,636 - $15,834
600 Added 97.09%
1,218 $21,000
Q2 2022

Aug 11, 2022

SELL
$20.49 - $39.72 $39,525 - $76,619
-1,929 Reduced 75.74%
618 $13,000
Q1 2022

May 12, 2022

SELL
$28.19 - $46.6 $105,712 - $174,750
-3,750 Reduced 59.55%
2,547 $94,000
Q4 2021

Feb 11, 2022

BUY
$41.2 - $73.6 $259,436 - $463,459
6,297 New
6,297 $286,000
Q1 2021

May 12, 2021

SELL
$57.62 - $95.6 $2.66 Million - $4.42 Million
-46,198 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$41.43 - $77.09 $1.91 Million - $3.56 Million
46,198 New
46,198 $3.35 Million
Q2 2020

Aug 13, 2020

SELL
$18.95 - $35.43 $36,023 - $67,352
-1,901 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$13.94 - $28.25 $76,502 - $155,036
-5,488 Reduced 74.27%
1,901 $42,000
Q4 2019

Feb 10, 2020

BUY
$19.24 - $28.41 $142,164 - $209,921
7,389 New
7,389 $159,000
Q1 2019

May 13, 2019

SELL
$22.09 - $39.21 $104,662 - $185,776
-4,738 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$19.89 - $30.02 $93,741 - $141,484
4,713 Added 18852.0%
4,738 $119,000
Q3 2018

Nov 08, 2018

BUY
$12.1 - $28.85 $302 - $721
25 New
25 $1,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.